Pre-Open Stock Movers 07/16: (GLG) (AEHR) (MGI) Higher; (FGEN) (AOUT) (CRVS) Lower (more...) Jul 16, 2021 09:30AM
After-Hours Stock Movers 07/15: (AEHR) (APT) (MRNA) Higher; (AOUT) (CRVS) Lower (more...) Jul 15, 2021 06:22PM
Notable Analyst Rating Changes 6/27: (GOLD) (GME) (ALXN) Upgraded; (RMD) (PCAR) (LYB) Downgraded Jun 27, 2016 10:24AM
Needham & Company Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Hot Quarter and Fiery Fundamentals Along with Sizzling Valuation Jul 22, 2011 08:37AM
Needham & Company Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Soliris Data at EHA Mtg Demonstrate Profound Treatment Effect Jun 13, 2011 07:58AM


Jun 1, 2011 10:49AM Needham & Company Maintains a 'Hold' on Alexion Pharmaceuticals (ALXN); Soliris sBLA for aHUS Gets Priority Review – A Positive Yet Well Expected News
Apr 25, 2011 07:53AM Needham & Company Downgrades Alexion Pharmaceuticals (ALXN) to Hold; Solid Company with Strong Fundamentals, Yet Near-Term Growth/Other Positives Already Priced In
Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference
Feb 11, 2011 08:08AM Needham & Company Raises PT on Alexion Pharmaceuticals (ALXN) Based on Chocolate (Strong Soliris Growth in Current PNH Markets) AND Flowers (Soliris in New Markets, Faster aHUS Submission, Pipeline wi
Jan 5, 2011 07:55AM Needham & Company Reiterates a 'Buy' on Alexion Pharmaceuticals (ALXN); Soliris Growth Momentum Continues
Nov 22, 2010 08:12AM Needham & Company reiterates a 'Buy' on Alexion Pharmaceuticals (ALXN); Impressive Data at ASN Meeting Highlight the Potential of Soliris in aHUS
Sep 27, 2010 08:14AM Needham & Company Maintains a 'Buy' on Alexion Pharmaceuticals (ALXN), Adjusting Estimates for Soliris Sales Upwards
Apr 23, 2010 08:29AM Needham & Company Maintains a 'Buy' on Alexion Pharmaceuticals (ALXN); Early 2Q10 Preview Shows Continued Growth From Geographic Expansion
Jul 23, 2009 10:01AM Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)